Colin Nixon

48PUBLICATIONS

388CO-AUTHORS

Predictive and prognostic markersMolecular targetsHaematological tumoursNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (48)

Sort by Publication Date:

|Jul 15, 2026

Multiscale in vivo imaging of tumor evolution using a germline conditional triple-reporter mouse.

|May 06, 2026

Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

|Mar 04, 2026

Vγ1 γδ T cells steer airway macrophages toward a profibrotic response in an autochthonous lung cancer mouse model.

Ximena L Raffo-Iraolagoitia, Amanda J McFarlane, Sarah Laing

|Jan 23, 2026

Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma.

Maria Francesca Allega, Ruhi Deshmukh, Theresa Hillinger

|Dec 18, 2025

Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.

Georgios Kanellos, Chiara Giacomelli, Alexander Raven

|Nov 25, 2025

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

Pageof 8

Frequent Collaborators

23 joint publications

Owen J Sansom

13 joint publications

Andrew D Campbell

13 joint publications

Karen Blyth

11 joint publications

Tom Bird

11 joint publications

David Sumpton

10 joint publications

Douglas Strathdee

Arafath K Najumudeen

Rachel A Ridgway

Kathryn Gilroy

Stephanie May

Frequent Collaborators

23 joint publications

Owen J Sansom

13 joint publications

Andrew D Campbell

13 joint publications

Karen Blyth

11 joint publications

Tom Bird